nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—breast cancer	0.326	1	CbGaD
Mannitol—ABCB1—Toremifene—breast cancer	0.0946	0.223	CbGbCtD
Mannitol—ABCB1—Lapatinib—breast cancer	0.069	0.162	CbGbCtD
Mannitol—ABCB1—Vinorelbine—breast cancer	0.0383	0.0901	CbGbCtD
Mannitol—ABCB1—Tamoxifen—breast cancer	0.0345	0.0813	CbGbCtD
Mannitol—ABCB1—Mitoxantrone—breast cancer	0.0337	0.0793	CbGbCtD
Mannitol—ABCB1—Gemcitabine—breast cancer	0.0298	0.0701	CbGbCtD
Mannitol—ABCB1—Paclitaxel—breast cancer	0.0269	0.0633	CbGbCtD
Mannitol—ABCB1—Irinotecan—breast cancer	0.0265	0.0624	CbGbCtD
Mannitol—ABCB1—Vinblastine—breast cancer	0.0236	0.0555	CbGbCtD
Mannitol—ABCB1—Docetaxel—breast cancer	0.0194	0.0458	CbGbCtD
Mannitol—ABCB1—Doxorubicin—breast cancer	0.0145	0.0341	CbGbCtD
Mannitol—ABCB1—Methotrexate—breast cancer	0.014	0.033	CbGbCtD
Mannitol—ABCB1—Codeine and Morphine Metabolism—SLCO1B1—breast cancer	0.000831	0.0805	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transmembrane transport—ABCG2—breast cancer	0.000614	0.0595	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PEX14—breast cancer	0.000509	0.0493	CbGpPWpGaD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—SLCO1B1—breast cancer	0.000455	0.044	CbGpPWpGaD
Mannitol—ABCB1—Codeine and Morphine Metabolism—CYP2D6—breast cancer	0.000369	0.0357	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transport and metabolism—ABCG2—breast cancer	0.000353	0.0342	CbGpPWpGaD
Mannitol—ABCB1—Codeine and Morphine Metabolism—CYP3A4—breast cancer	0.000325	0.0315	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SLC4A7—breast cancer	0.000267	0.0259	CbGpPWpGaD
Mannitol—ABCB1—ABC-family proteins mediated transport—ABCC1—breast cancer	0.000183	0.0177	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.000179	0.0173	CbGpPWpGaD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—breast cancer	0.000178	0.0172	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.000177	0.0171	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—breast cancer	0.000168	0.0163	CbGpPWpGaD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—breast cancer	0.000149	0.0144	CbGpPWpGaD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.000144	0.0139	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—breast cancer	0.000143	0.0138	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.000119	0.0116	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NDRG1—breast cancer	0.000112	0.0109	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—RB1CC1—breast cancer	0.00011	0.0107	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—breast cancer	0.000107	0.0104	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.000103	0.01	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CA9—breast cancer	0.000103	0.00996	CbGpPWpGaD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—breast cancer	0.000102	0.00989	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.000101	0.00974	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—breast cancer	9.89e-05	0.00958	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—breast cancer	8.37e-05	0.00811	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—ALDOA—breast cancer	8.25e-05	0.00799	CbGpPWpGaD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	8.25e-05	0.00799	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—ABCG2—breast cancer	7.79e-05	0.00755	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—FOXP3—breast cancer	7.64e-05	0.0074	CbGpPWpGaD
Mannitol—Renal failure—Epirubicin—breast cancer	7.37e-05	0.000308	CcSEcCtD
Mannitol—Asthenia—Irinotecan—breast cancer	7.36e-05	0.000308	CcSEcCtD
Mannitol—Asthenia—Mitoxantrone—breast cancer	7.36e-05	0.000308	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.35e-05	0.000307	CcSEcCtD
Mannitol—Cough—Capecitabine—breast cancer	7.34e-05	0.000307	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—breast cancer	7.31e-05	0.000306	CcSEcCtD
Mannitol—Decreased appetite—Paclitaxel—breast cancer	7.27e-05	0.000304	CcSEcCtD
Mannitol—Hypertension—Capecitabine—breast cancer	7.26e-05	0.000304	CcSEcCtD
Mannitol—Hypersensitivity—Fluorouracil—breast cancer	7.24e-05	0.000303	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—breast cancer	7.23e-05	0.000303	CcSEcCtD
Mannitol—Gastrointestinal disorder—Paclitaxel—breast cancer	7.22e-05	0.000302	CcSEcCtD
Mannitol—Fatigue—Paclitaxel—breast cancer	7.21e-05	0.000302	CcSEcCtD
Mannitol—Asthenia—Gemcitabine—breast cancer	7.17e-05	0.0003	CcSEcCtD
Mannitol—Chest pain—Capecitabine—breast cancer	7.16e-05	0.0003	CcSEcCtD
Mannitol—Arthralgia—Capecitabine—breast cancer	7.16e-05	0.0003	CcSEcCtD
Mannitol—Pain—Paclitaxel—breast cancer	7.15e-05	0.000299	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—breast cancer	7.14e-05	0.000299	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—breast cancer	7.11e-05	0.00689	CbGpPWpGaD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.11e-05	0.000297	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—breast cancer	7.1e-05	0.000297	CcSEcCtD
Mannitol—Oedema—Docetaxel—breast cancer	7.09e-05	0.000297	CcSEcCtD
Mannitol—Discomfort—Capecitabine—breast cancer	7.08e-05	0.000296	CcSEcCtD
Mannitol—Pruritus—Gemcitabine—breast cancer	7.07e-05	0.000296	CcSEcCtD
Mannitol—Nausea—Thiotepa—breast cancer	7.06e-05	0.000295	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—breast cancer	7.05e-05	0.000295	CcSEcCtD
Mannitol—Infection—Docetaxel—breast cancer	7.05e-05	0.000295	CcSEcCtD
Mannitol—Diarrhoea—Mitoxantrone—breast cancer	7.02e-05	0.000294	CcSEcCtD
Mannitol—Diarrhoea—Irinotecan—breast cancer	7.02e-05	0.000294	CcSEcCtD
Mannitol—Nervous system disorder—Docetaxel—breast cancer	6.95e-05	0.000291	CcSEcCtD
Mannitol—Pruritus—Fluorouracil—breast cancer	6.95e-05	0.000291	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—ENO1—breast cancer	6.95e-05	0.00673	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—TFRC—breast cancer	6.95e-05	0.00673	CbGpPWpGaD
Mannitol—Infestation—Doxorubicin—breast cancer	6.94e-05	0.00029	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—breast cancer	6.94e-05	0.00029	CcSEcCtD
Mannitol—Tachycardia—Docetaxel—breast cancer	6.92e-05	0.000289	CcSEcCtD
Mannitol—Feeling abnormal—Paclitaxel—breast cancer	6.89e-05	0.000288	CcSEcCtD
Mannitol—Skin disorder—Docetaxel—breast cancer	6.89e-05	0.000288	CcSEcCtD
Mannitol—Oedema—Capecitabine—breast cancer	6.87e-05	0.000287	CcSEcCtD
Mannitol—Diarrhoea—Gemcitabine—breast cancer	6.84e-05	0.000286	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—breast cancer	6.82e-05	0.000285	CcSEcCtD
Mannitol—Infection—Capecitabine—breast cancer	6.82e-05	0.000285	CcSEcCtD
Mannitol—Dizziness—Irinotecan—breast cancer	6.78e-05	0.000284	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—breast cancer	6.76e-05	0.000283	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—breast cancer	6.75e-05	0.000282	CcSEcCtD
Mannitol—Nervous system disorder—Capecitabine—breast cancer	6.73e-05	0.000282	CcSEcCtD
Mannitol—Diarrhoea—Fluorouracil—breast cancer	6.72e-05	0.000281	CcSEcCtD
Mannitol—Tachycardia—Capecitabine—breast cancer	6.7e-05	0.00028	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NCOA2—breast cancer	6.69e-05	0.00648	CbGpPWpGaD
Mannitol—Pharyngitis—Epirubicin—breast cancer	6.68e-05	0.000279	CcSEcCtD
Mannitol—Skin disorder—Capecitabine—breast cancer	6.67e-05	0.000279	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—breast cancer	6.65e-05	0.000278	CcSEcCtD
Mannitol—Urticaria—Paclitaxel—breast cancer	6.65e-05	0.000278	CcSEcCtD
Mannitol—Hypotension—Docetaxel—breast cancer	6.63e-05	0.000277	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—breast cancer	6.62e-05	0.000277	CcSEcCtD
Mannitol—Body temperature increased—Paclitaxel—breast cancer	6.61e-05	0.000277	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—breast cancer	6.6e-05	0.000276	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—GZMB—breast cancer	6.54e-05	0.00633	CbGpPWpGaD
Mannitol—Vomiting—Mitoxantrone—breast cancer	6.52e-05	0.000273	CcSEcCtD
Mannitol—Vomiting—Irinotecan—breast cancer	6.52e-05	0.000273	CcSEcCtD
Mannitol—Dizziness—Fluorouracil—breast cancer	6.5e-05	0.000272	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—breast cancer	6.48e-05	0.000271	CcSEcCtD
Mannitol—Rash—Irinotecan—breast cancer	6.47e-05	0.000271	CcSEcCtD
Mannitol—Rash—Mitoxantrone—breast cancer	6.47e-05	0.000271	CcSEcCtD
Mannitol—Dermatitis—Mitoxantrone—breast cancer	6.46e-05	0.00027	CcSEcCtD
Mannitol—Dermatitis—Irinotecan—breast cancer	6.46e-05	0.00027	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Docetaxel—breast cancer	6.46e-05	0.00027	CcSEcCtD
Mannitol—Chills—Methotrexate—breast cancer	6.46e-05	0.00027	CcSEcCtD
Mannitol—Headache—Irinotecan—breast cancer	6.43e-05	0.000269	CcSEcCtD
Mannitol—Headache—Mitoxantrone—breast cancer	6.43e-05	0.000269	CcSEcCtD
Mannitol—Hypotension—Capecitabine—breast cancer	6.42e-05	0.000268	CcSEcCtD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—breast cancer	6.37e-05	0.00617	CbGpPWpGaD
Mannitol—Vomiting—Gemcitabine—breast cancer	6.35e-05	0.000266	CcSEcCtD
Mannitol—Dyspnoea—Docetaxel—breast cancer	6.32e-05	0.000264	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—breast cancer	6.3e-05	0.000264	CcSEcCtD
Mannitol—Rash—Gemcitabine—breast cancer	6.3e-05	0.000264	CcSEcCtD
Mannitol—Dermatitis—Gemcitabine—breast cancer	6.29e-05	0.000263	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—breast cancer	6.26e-05	0.000262	CcSEcCtD
Mannitol—Headache—Gemcitabine—breast cancer	6.26e-05	0.000262	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Capecitabine—breast cancer	6.26e-05	0.000262	CcSEcCtD
Mannitol—Vomiting—Fluorouracil—breast cancer	6.25e-05	0.000261	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—breast cancer	6.25e-05	0.000261	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CXCR4—breast cancer	6.23e-05	0.00603	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CXCL12—breast cancer	6.23e-05	0.00603	CbGpPWpGaD
Mannitol—Rash—Fluorouracil—breast cancer	6.19e-05	0.000259	CcSEcCtD
Mannitol—Dermatitis—Fluorouracil—breast cancer	6.19e-05	0.000259	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—breast cancer	6.18e-05	0.000259	CcSEcCtD
Mannitol—Decreased appetite—Docetaxel—breast cancer	6.16e-05	0.000258	CcSEcCtD
Mannitol—Hypersensitivity—Paclitaxel—breast cancer	6.16e-05	0.000258	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—breast cancer	6.16e-05	0.00597	CbGpPWpGaD
Mannitol—Headache—Fluorouracil—breast cancer	6.16e-05	0.000257	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—breast cancer	6.15e-05	0.000257	CcSEcCtD
Mannitol—Gastrointestinal disorder—Docetaxel—breast cancer	6.12e-05	0.000256	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—breast cancer	6.12e-05	0.000256	CcSEcCtD
Mannitol—Dyspnoea—Capecitabine—breast cancer	6.12e-05	0.000256	CcSEcCtD
Mannitol—Fatigue—Docetaxel—breast cancer	6.11e-05	0.000256	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—breast cancer	6.11e-05	0.000255	CcSEcCtD
Mannitol—Nausea—Mitoxantrone—breast cancer	6.09e-05	0.000255	CcSEcCtD
Mannitol—Nausea—Irinotecan—breast cancer	6.09e-05	0.000255	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—breast cancer	6.07e-05	0.000254	CcSEcCtD
Mannitol—Pain—Docetaxel—breast cancer	6.06e-05	0.000254	CcSEcCtD
Mannitol—Back pain—Methotrexate—breast cancer	6.06e-05	0.000253	CcSEcCtD
Mannitol—Chills—Epirubicin—breast cancer	6.04e-05	0.000253	CcSEcCtD
Mannitol—Asthenia—Paclitaxel—breast cancer	6e-05	0.000251	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CASP7—breast cancer	5.99e-05	0.0058	CbGpPWpGaD
Mannitol—Decreased appetite—Capecitabine—breast cancer	5.97e-05	0.00025	CcSEcCtD
Mannitol—Nausea—Gemcitabine—breast cancer	5.94e-05	0.000248	CcSEcCtD
Mannitol—Gastrointestinal disorder—Capecitabine—breast cancer	5.93e-05	0.000248	CcSEcCtD
Mannitol—Fatigue—Capecitabine—breast cancer	5.92e-05	0.000248	CcSEcCtD
Mannitol—Pruritus—Paclitaxel—breast cancer	5.92e-05	0.000248	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—breast cancer	5.9e-05	0.000247	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—breast cancer	5.9e-05	0.000247	CcSEcCtD
Mannitol—Pain—Capecitabine—breast cancer	5.87e-05	0.000246	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—breast cancer	5.86e-05	0.000245	CcSEcCtD
Mannitol—Feeling abnormal—Docetaxel—breast cancer	5.84e-05	0.000244	CcSEcCtD
Mannitol—Nausea—Fluorouracil—breast cancer	5.84e-05	0.000244	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—breast cancer	5.81e-05	0.000243	CcSEcCtD
Mannitol—Flatulence—Epirubicin—breast cancer	5.78e-05	0.000242	CcSEcCtD
Mannitol—Diarrhoea—Paclitaxel—breast cancer	5.72e-05	0.000239	CcSEcCtD
Mannitol—Nervousness—Epirubicin—breast cancer	5.69e-05	0.000238	CcSEcCtD
Mannitol—Back pain—Epirubicin—breast cancer	5.67e-05	0.000237	CcSEcCtD
Mannitol—Feeling abnormal—Capecitabine—breast cancer	5.66e-05	0.000237	CcSEcCtD
Mannitol—Malaise—Methotrexate—breast cancer	5.65e-05	0.000236	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NCOA1—breast cancer	5.63e-05	0.00546	CbGpPWpGaD
Mannitol—Vertigo—Methotrexate—breast cancer	5.63e-05	0.000235	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—breast cancer	5.61e-05	0.000235	CcSEcCtD
Mannitol—Body temperature increased—Docetaxel—breast cancer	5.61e-05	0.000234	CcSEcCtD
Mannitol—Chills—Doxorubicin—breast cancer	5.59e-05	0.000234	CcSEcCtD
Mannitol—Dizziness—Paclitaxel—breast cancer	5.53e-05	0.000231	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—breast cancer	5.52e-05	0.000231	CcSEcCtD
Mannitol—Cough—Methotrexate—breast cancer	5.46e-05	0.000229	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—breast cancer	5.46e-05	0.000228	CcSEcCtD
Mannitol—Urticaria—Capecitabine—breast cancer	5.45e-05	0.000228	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—breast cancer	5.44e-05	0.000227	CcSEcCtD
Mannitol—Body temperature increased—Capecitabine—breast cancer	5.43e-05	0.000227	CcSEcCtD
Mannitol—Convulsion—Methotrexate—breast cancer	5.43e-05	0.000227	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—breast cancer	5.42e-05	0.000227	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CXCL12—breast cancer	5.4e-05	0.00523	CbGpPWpGaD
Mannitol—Flatulence—Doxorubicin—breast cancer	5.34e-05	0.000223	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CD40—breast cancer	5.34e-05	0.00517	CbGpPWpGaD
Mannitol—Arthralgia—Methotrexate—breast cancer	5.33e-05	0.000223	CcSEcCtD
Mannitol—Chest pain—Methotrexate—breast cancer	5.33e-05	0.000223	CcSEcCtD
Mannitol—Vomiting—Paclitaxel—breast cancer	5.32e-05	0.000222	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.29e-05	0.000221	CcSEcCtD
Mannitol—Malaise—Epirubicin—breast cancer	5.29e-05	0.000221	CcSEcCtD
Mannitol—Rash—Paclitaxel—breast cancer	5.28e-05	0.000221	CcSEcCtD
Mannitol—Dermatitis—Paclitaxel—breast cancer	5.27e-05	0.00022	CcSEcCtD
Mannitol—Discomfort—Methotrexate—breast cancer	5.27e-05	0.00022	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—breast cancer	5.27e-05	0.00022	CcSEcCtD
Mannitol—Vertigo—Epirubicin—breast cancer	5.27e-05	0.00022	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CTLA4—breast cancer	5.26e-05	0.00509	CbGpPWpGaD
Mannitol—Back pain—Doxorubicin—breast cancer	5.25e-05	0.000219	CcSEcCtD
Mannitol—Headache—Paclitaxel—breast cancer	5.24e-05	0.000219	CcSEcCtD
Mannitol—Hypersensitivity—Docetaxel—breast cancer	5.22e-05	0.000219	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—breast cancer	5.17e-05	0.00501	CbGpPWpGaD
Mannitol—Cough—Epirubicin—breast cancer	5.11e-05	0.000214	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—breast cancer	5.11e-05	0.000214	CcSEcCtD
Mannitol—Asthenia—Docetaxel—breast cancer	5.09e-05	0.000213	CcSEcCtD
Mannitol—Convulsion—Epirubicin—breast cancer	5.08e-05	0.000212	CcSEcCtD
Mannitol—Infection—Methotrexate—breast cancer	5.08e-05	0.000212	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—breast cancer	5.07e-05	0.00491	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—HMOX1—breast cancer	5.07e-05	0.00491	CbGpPWpGaD
Mannitol—Hypertension—Epirubicin—breast cancer	5.06e-05	0.000212	CcSEcCtD
Mannitol—Hypersensitivity—Capecitabine—breast cancer	5.06e-05	0.000212	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—breast cancer	5.03e-05	0.00021	CcSEcCtD
Mannitol—Pruritus—Docetaxel—breast cancer	5.02e-05	0.00021	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—breast cancer	5.01e-05	0.00021	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—breast cancer	4.99e-05	0.000209	CcSEcCtD
Mannitol—Chest pain—Epirubicin—breast cancer	4.99e-05	0.000209	CcSEcCtD
Mannitol—Nausea—Paclitaxel—breast cancer	4.97e-05	0.000208	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—breast cancer	4.96e-05	0.000208	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.96e-05	0.000207	CcSEcCtD
Mannitol—Discomfort—Epirubicin—breast cancer	4.93e-05	0.000206	CcSEcCtD
Mannitol—Asthenia—Capecitabine—breast cancer	4.93e-05	0.000206	CcSEcCtD
Mannitol—Malaise—Doxorubicin—breast cancer	4.89e-05	0.000205	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—AGTR1—breast cancer	4.88e-05	0.00473	CbGpPWpGaD
Mannitol—Vertigo—Doxorubicin—breast cancer	4.87e-05	0.000204	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—SMAD4—breast cancer	4.86e-05	0.00471	CbGpPWpGaD
Mannitol—Pruritus—Capecitabine—breast cancer	4.86e-05	0.000203	CcSEcCtD
Mannitol—Diarrhoea—Docetaxel—breast cancer	4.85e-05	0.000203	CcSEcCtD
Mannitol—Oedema—Epirubicin—breast cancer	4.78e-05	0.0002	CcSEcCtD
Mannitol—Hypotension—Methotrexate—breast cancer	4.78e-05	0.0002	CcSEcCtD
Mannitol—Infection—Epirubicin—breast cancer	4.75e-05	0.000199	CcSEcCtD
Mannitol—Cough—Doxorubicin—breast cancer	4.73e-05	0.000198	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—breast cancer	4.7e-05	0.000196	CcSEcCtD
Mannitol—Diarrhoea—Capecitabine—breast cancer	4.7e-05	0.000196	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—breast cancer	4.69e-05	0.000196	CcSEcCtD
Mannitol—Dizziness—Docetaxel—breast cancer	4.69e-05	0.000196	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—breast cancer	4.68e-05	0.000196	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—breast cancer	4.67e-05	0.000195	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—breast cancer	4.66e-05	0.000195	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—breast cancer	4.65e-05	0.000194	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—breast cancer	4.62e-05	0.000193	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—breast cancer	4.62e-05	0.000193	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.58e-05	0.000192	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—breast cancer	4.56e-05	0.000191	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—breast cancer	4.56e-05	0.000191	CcSEcCtD
Mannitol—Dizziness—Capecitabine—breast cancer	4.54e-05	0.00019	CcSEcCtD
Mannitol—Vomiting—Docetaxel—breast cancer	4.51e-05	0.000189	CcSEcCtD
Mannitol—Rash—Docetaxel—breast cancer	4.47e-05	0.000187	CcSEcCtD
Mannitol—Hypotension—Epirubicin—breast cancer	4.47e-05	0.000187	CcSEcCtD
Mannitol—Dermatitis—Docetaxel—breast cancer	4.47e-05	0.000187	CcSEcCtD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—breast cancer	4.45e-05	0.00431	CbGpPWpGaD
Mannitol—Decreased appetite—Methotrexate—breast cancer	4.44e-05	0.000186	CcSEcCtD
Mannitol—Headache—Docetaxel—breast cancer	4.44e-05	0.000186	CcSEcCtD
Mannitol—Oedema—Doxorubicin—breast cancer	4.43e-05	0.000185	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—breast cancer	4.41e-05	0.000185	CcSEcCtD
Mannitol—Fatigue—Methotrexate—breast cancer	4.41e-05	0.000184	CcSEcCtD
Mannitol—Infection—Doxorubicin—breast cancer	4.4e-05	0.000184	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MRE11A—breast cancer	4.39e-05	0.00426	CbGpPWpGaD
Mannitol—Pain—Methotrexate—breast cancer	4.37e-05	0.000183	CcSEcCtD
Mannitol—Vomiting—Capecitabine—breast cancer	4.37e-05	0.000183	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—breast cancer	4.36e-05	0.000182	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—breast cancer	4.34e-05	0.000182	CcSEcCtD
Mannitol—Rash—Capecitabine—breast cancer	4.33e-05	0.000181	CcSEcCtD
Mannitol—Dermatitis—Capecitabine—breast cancer	4.32e-05	0.000181	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—breast cancer	4.32e-05	0.000181	CcSEcCtD
Mannitol—Headache—Capecitabine—breast cancer	4.3e-05	0.00018	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—breast cancer	4.3e-05	0.00018	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FST—breast cancer	4.28e-05	0.00415	CbGpPWpGaD
Mannitol—Dyspnoea—Epirubicin—breast cancer	4.26e-05	0.000178	CcSEcCtD
Mannitol—Nausea—Docetaxel—breast cancer	4.21e-05	0.000176	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—breast cancer	4.21e-05	0.000176	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—TERT—breast cancer	4.16e-05	0.00403	CbGpPWpGaD
Mannitol—Decreased appetite—Epirubicin—breast cancer	4.16e-05	0.000174	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—breast cancer	4.14e-05	0.000173	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—breast cancer	4.13e-05	0.000173	CcSEcCtD
Mannitol—Fatigue—Epirubicin—breast cancer	4.12e-05	0.000172	CcSEcCtD
Mannitol—Pain—Epirubicin—breast cancer	4.09e-05	0.000171	CcSEcCtD
Mannitol—Nausea—Capecitabine—breast cancer	4.08e-05	0.000171	CcSEcCtD
Mannitol—Urticaria—Methotrexate—breast cancer	4.06e-05	0.00017	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—breast cancer	4.04e-05	0.000169	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.03e-05	0.000169	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—HIF1A—breast cancer	3.98e-05	0.00385	CbGpPWpGaD
Mannitol—Dyspnoea—Doxorubicin—breast cancer	3.95e-05	0.000165	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—breast cancer	3.94e-05	0.000165	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC28A1—breast cancer	3.91e-05	0.00378	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—LEP—breast cancer	3.88e-05	0.00376	CbGpPWpGaD
Mannitol—Decreased appetite—Doxorubicin—breast cancer	3.85e-05	0.000161	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—breast cancer	3.82e-05	0.00016	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—breast cancer	3.82e-05	0.00016	CcSEcCtD
Mannitol—Urticaria—Epirubicin—breast cancer	3.8e-05	0.000159	CcSEcCtD
Mannitol—Pain—Doxorubicin—breast cancer	3.78e-05	0.000158	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—breast cancer	3.78e-05	0.000158	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—breast cancer	3.77e-05	0.000157	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—breast cancer	3.74e-05	0.00362	CbGpPWpGaD
Mannitol—Asthenia—Methotrexate—breast cancer	3.67e-05	0.000153	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—breast cancer	3.65e-05	0.000153	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—breast cancer	3.64e-05	0.00353	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NOS2—breast cancer	3.62e-05	0.00351	CbGpPWpGaD
Mannitol—Pruritus—Methotrexate—breast cancer	3.62e-05	0.000151	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC4A7—breast cancer	3.57e-05	0.00346	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC2A10—breast cancer	3.57e-05	0.00346	CbGpPWpGaD
Mannitol—Hypersensitivity—Epirubicin—breast cancer	3.52e-05	0.000147	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—breast cancer	3.52e-05	0.000147	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—breast cancer	3.5e-05	0.000146	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—breast cancer	3.5e-05	0.000146	CcSEcCtD
Mannitol—Asthenia—Epirubicin—breast cancer	3.43e-05	0.000144	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—breast cancer	3.4e-05	0.00329	CbGpPWpGaD
Mannitol—Pruritus—Epirubicin—breast cancer	3.38e-05	0.000142	CcSEcCtD
Mannitol—Dizziness—Methotrexate—breast cancer	3.38e-05	0.000141	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—FOS—breast cancer	3.34e-05	0.00324	CbGpPWpGaD
Mannitol—Diarrhoea—Epirubicin—breast cancer	3.27e-05	0.000137	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—breast cancer	3.27e-05	0.00316	CbGpPWpGaD
Mannitol—Hypersensitivity—Doxorubicin—breast cancer	3.26e-05	0.000136	CcSEcCtD
Mannitol—Vomiting—Methotrexate—breast cancer	3.25e-05	0.000136	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—breast cancer	3.25e-05	0.00314	CbGpPWpGaD
Mannitol—Rash—Methotrexate—breast cancer	3.22e-05	0.000135	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—breast cancer	3.22e-05	0.000135	CcSEcCtD
Mannitol—Headache—Methotrexate—breast cancer	3.2e-05	0.000134	CcSEcCtD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—breast cancer	3.2e-05	0.0031	CbGpPWpGaD
Mannitol—Asthenia—Doxorubicin—breast cancer	3.18e-05	0.000133	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—breast cancer	3.17e-05	0.00307	CbGpPWpGaD
Mannitol—Dizziness—Epirubicin—breast cancer	3.16e-05	0.000132	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—breast cancer	3.13e-05	0.000131	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—breast cancer	3.05e-05	0.00295	CbGpPWpGaD
Mannitol—Vomiting—Epirubicin—breast cancer	3.04e-05	0.000127	CcSEcCtD
Mannitol—Nausea—Methotrexate—breast cancer	3.04e-05	0.000127	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—breast cancer	3.03e-05	0.000127	CcSEcCtD
Mannitol—Rash—Epirubicin—breast cancer	3.02e-05	0.000126	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—breast cancer	3.01e-05	0.000126	CcSEcCtD
Mannitol—Headache—Epirubicin—breast cancer	3e-05	0.000125	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—breast cancer	2.97e-05	0.00287	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—COX11—breast cancer	2.96e-05	0.00287	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC39A7—breast cancer	2.96e-05	0.00287	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	2.95e-05	0.00286	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	2.95e-05	0.00286	CbGpPWpGaD
Mannitol—Dizziness—Doxorubicin—breast cancer	2.93e-05	0.000122	CcSEcCtD
Mannitol—Nausea—Epirubicin—breast cancer	2.84e-05	0.000119	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CASP8—breast cancer	2.83e-05	0.00274	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	2.82e-05	0.00273	CbGpPWpGaD
Mannitol—Vomiting—Doxorubicin—breast cancer	2.81e-05	0.000118	CcSEcCtD
Mannitol—Rash—Doxorubicin—breast cancer	2.79e-05	0.000117	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—breast cancer	2.79e-05	0.000117	CcSEcCtD
Mannitol—Headache—Doxorubicin—breast cancer	2.77e-05	0.000116	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC22A18—breast cancer	2.71e-05	0.00262	CbGpPWpGaD
Mannitol—Nausea—Doxorubicin—breast cancer	2.63e-05	0.00011	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	2.61e-05	0.00253	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	2.61e-05	0.00253	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC2A5—breast cancer	2.61e-05	0.00252	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	2.61e-05	0.00252	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	2.53e-05	0.00245	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—breast cancer	2.45e-05	0.00237	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	2.44e-05	0.00237	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IFNG—breast cancer	2.4e-05	0.00233	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—JUN—breast cancer	2.4e-05	0.00232	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	2.37e-05	0.0023	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	2.37e-05	0.0023	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—AR—breast cancer	2.31e-05	0.00224	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC39A6—breast cancer	2.24e-05	0.00217	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CXCL8—breast cancer	2.24e-05	0.00217	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	2.23e-05	0.00216	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	2.15e-05	0.00208	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	2.15e-05	0.00208	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	2.15e-05	0.00208	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL1B—breast cancer	2.14e-05	0.00208	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CASP3—breast cancer	2.14e-05	0.00207	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL2—breast cancer	2.14e-05	0.00207	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	2.1e-05	0.00204	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	2.1e-05	0.00203	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	2.08e-05	0.00201	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	2.08e-05	0.00201	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	2.05e-05	0.00199	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	2.04e-05	0.00198	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	2.02e-05	0.00195	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	2e-05	0.00193	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	1.97e-05	0.0019	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	1.95e-05	0.00189	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	1.91e-05	0.00185	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—VEGFA—breast cancer	1.82e-05	0.00176	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	1.73e-05	0.00167	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	1.68e-05	0.00163	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SYNJ2—breast cancer	1.67e-05	0.00162	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—TGFB1—breast cancer	1.67e-05	0.00161	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	1.62e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	1.6e-05	0.00155	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	1.59e-05	0.00154	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	1.59e-05	0.00154	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—TNF—breast cancer	1.56e-05	0.00151	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NDUFS3—breast cancer	1.56e-05	0.00151	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	1.55e-05	0.0015	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	1.5e-05	0.00145	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	1.48e-05	0.00143	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CHST9—breast cancer	1.46e-05	0.00142	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	1.4e-05	0.00135	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—COX11—breast cancer	1.39e-05	0.00134	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	1.37e-05	0.00133	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.35e-05	0.00131	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	1.34e-05	0.0013	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	1.32e-05	0.00128	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CDA—breast cancer	1.27e-05	0.00123	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SHMT1—breast cancer	1.27e-05	0.00123	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLCO1B1—breast cancer	1.22e-05	0.00118	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC2A5—breast cancer	1.22e-05	0.00118	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.2e-05	0.00116	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.18e-05	0.00114	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—APRT—breast cancer	1.18e-05	0.00114	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.18e-05	0.00114	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.18e-05	0.00114	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.16e-05	0.00113	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.14e-05	0.0011	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.13e-05	0.0011	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ESRRA—breast cancer	1.11e-05	0.00107	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ANGPTL4—breast cancer	1.11e-05	0.00107	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.08e-05	0.00105	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.08e-05	0.00104	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.06e-05	0.00102	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HADHB—breast cancer	1.05e-05	0.00102	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GPI—breast cancer	1.05e-05	0.00102	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.05e-05	0.00101	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.03e-05	0.000995	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.03e-05	0.000993	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.02e-05	0.000986	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ALDH1A1—breast cancer	1e-05	0.000971	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ALDH7A1—breast cancer	1e-05	0.000971	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	9.94e-06	0.000963	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	9.92e-06	0.000961	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	9.71e-06	0.00094	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PHGDH—breast cancer	9.61e-06	0.000931	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ADSL—breast cancer	9.61e-06	0.000931	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NME1—breast cancer	9.61e-06	0.000931	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—FHL2—breast cancer	9.61e-06	0.000931	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—UMPS—breast cancer	9.61e-06	0.000931	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	9.56e-06	0.000926	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HPSE—breast cancer	9.43e-06	0.000913	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—BRIP1—breast cancer	9.43e-06	0.000913	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—LDHB—breast cancer	9.43e-06	0.000913	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	9.32e-06	0.000902	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	9.2e-06	0.000891	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	8.96e-06	0.000868	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ABCC1—breast cancer	8.94e-06	0.000865	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HMMR—breast cancer	8.94e-06	0.000865	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA3—breast cancer	8.94e-06	0.000865	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PPARGC1B—breast cancer	8.65e-06	0.000838	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	8.6e-06	0.000833	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	8.48e-06	0.000821	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	8.24e-06	0.000798	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	8.22e-06	0.000797	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CA9—breast cancer	8.17e-06	0.000791	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA4—breast cancer	8.17e-06	0.000791	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	8.06e-06	0.000781	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GPX2—breast cancer	7.96e-06	0.000771	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA2—breast cancer	7.96e-06	0.000771	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SULT1A1—breast cancer	7.87e-06	0.000762	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GPX4—breast cancer	7.87e-06	0.000762	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—IDH1—breast cancer	7.68e-06	0.000744	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA1—breast cancer	7.68e-06	0.000744	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	7.68e-06	0.000744	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	7.62e-06	0.000738	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NAT2—breast cancer	7.6e-06	0.000736	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	7e-06	0.000678	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	6.77e-06	0.000656	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—DPYD—breast cancer	6.66e-06	0.000645	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MED12—breast cancer	6.66e-06	0.000645	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ALDOA—breast cancer	6.56e-06	0.000635	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA3—breast cancer	6.37e-06	0.000617	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC2A2—breast cancer	6.32e-06	0.000612	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ABCG2—breast cancer	6.19e-06	0.0006	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CPT1A—breast cancer	6.19e-06	0.0006	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTR—breast cancer	6.19e-06	0.0006	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HPGDS—breast cancer	6.07e-06	0.000588	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HBA1—breast cancer	6.04e-06	0.000585	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTT1—breast cancer	5.89e-06	0.000571	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ACHE—breast cancer	5.89e-06	0.000571	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	5.72e-06	0.000554	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP17A1—breast cancer	5.58e-06	0.00054	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PTGS1—breast cancer	5.52e-06	0.000535	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ENO1—breast cancer	5.52e-06	0.000535	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP2D6—breast cancer	5.41e-06	0.000524	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA2—breast cancer	5.31e-06	0.000515	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	5.16e-06	0.0005	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—FASN—breast cancer	5.15e-06	0.000499	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—BCHE—breast cancer	5.13e-06	0.000497	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC5A5—breast cancer	5.07e-06	0.000491	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NQO1—breast cancer	4.9e-06	0.000474	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC2A1—breast cancer	4.9e-06	0.000474	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP3A4—breast cancer	4.77e-06	0.000462	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP1B1—breast cancer	4.69e-06	0.000455	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	4.67e-06	0.000452	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HSP90AA1—breast cancer	4.6e-06	0.000446	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA1—breast cancer	4.48e-06	0.000434	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP19A1—breast cancer	4.41e-06	0.000427	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—STK11—breast cancer	4.41e-06	0.000427	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—COMT—breast cancer	4.1e-06	0.000397	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTP1—breast cancer	4.08e-06	0.000395	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HMOX1—breast cancer	4.03e-06	0.00039	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ITPR1—breast cancer	4.02e-06	0.000389	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TYMS—breast cancer	3.8e-06	0.000368	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTM1—breast cancer	3.75e-06	0.000363	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOR1—breast cancer	3.75e-06	0.000363	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PLA2G4A—breast cancer	3.75e-06	0.000363	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GPX1—breast cancer	3.59e-06	0.000348	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP1A1—breast cancer	3.56e-06	0.000345	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ERCC2—breast cancer	3.53e-06	0.000342	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTHFR—breast cancer	3.32e-06	0.000321	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CAV1—breast cancer	3.06e-06	0.000296	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CG—breast cancer	2.79e-06	0.00027	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CD—breast cancer	2.45e-06	0.000237	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ALB—breast cancer	2.42e-06	0.000234	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NOS3—breast cancer	2.31e-06	0.000224	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CB—breast cancer	2.14e-06	0.000207	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PTGS2—breast cancer	2.12e-06	0.000205	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PTEN—breast cancer	1.85e-06	0.000179	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CA—breast cancer	1.3e-06	0.000126	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AKT1—breast cancer	1.06e-06	0.000103	CbGpPWpGaD
